ECONOMY. The investment bank UBS has raised its target price for Philip Morris International from $168 to $182. This follows several key decisions by the US Food and Drug Administration (FDA).
The European Commission considers that France’s controversial ban on nicotine pouches is compatible with EU law. This is clear from a response from Health Commissioner Olivér Várhelyi, following calls from Swedish MEPs for the Commission to take action against the French rules.
A ban on flavourings, plain packaging, stricter advertising rules and the same legislation for all nicotine products. These are some of the demands highlighted by Swedish public health organisations and experts in their responses to the European Commission’s consultation on the forthcoming Tobacco Products Directive (TPD3).
New studies show that white snus affects the oral mucosa differently from traditional snus. At the same time, there is growing interest in how product development can reduce irritation – an issue that entrepreneur Bengt Wiberg has been championing for several years.
People who use white snus instead of smoking cigarettes are at a lower risk of developing oral cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. This has now been confirmed by the US Food and Drug Administration (FDA).
